Back to User profile » Dr Tongwen Ou

Papers published by Dr Tongwen Ou:

Retraction

LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis [Retraction]

Bi H, Shang Z, Jia C, Wu J, Cui B, Wang Q, Ou T

OncoTargets and Therapy 2022, 15:681-682

Published Date: 15 June 2022

Original Research

KLF16 Downregulates the Expression of Tumor Suppressor Gene TGFBR3 to Promote Bladder Cancer Proliferation and Migration

Chen X, Wang P, Ou T, Li J

Cancer Management and Research 2022, 14:465-477

Published Date: 9 February 2022

Original Research

LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis

Bi H, Shang Z, Jia C, Wu J, Cui B, Wang Q, Ou T

OncoTargets and Therapy 2020, 13:11277-11288

Published Date: 4 November 2020

Original Research

Predictive Values of Preoperative Prognostic Nutritional Index and Systemic Immune-Inflammation Index for Long-Term Survival in High-Risk Non-Muscle-Invasive Bladder Cancer Patients: A Single-Centre Retrospective Study

Bi H, Shang Z, Jia C, Wu J, Cui B, Wang Q, Ou T

Cancer Management and Research 2020, 12:9471-9483

Published Date: 1 October 2020

Original Research

Preoperative serum apolipoprotein A-I levels predict long-term survival in non-muscle-invasive bladder cancer patients

Shang Z, Wang J, Wang X, Yan H, Cui B, Jia C, Wang Q, Cui X, Li J, Ou T

Cancer Management and Research 2018, 10:1177-1190

Published Date: 14 May 2018